This Justification (J&A) opportunity from Department Of Veterans Affairs was posted on February 5, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Lenalidomide Generic Med
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Department of Veterans Affairs, through Network Contracting Office 17, is establishing a reliable supply of generic Lenalidomide to treat multiple myeloma, lymphoma, and anemia in myelodysplastic syndromes for approximately 50 patients at the West Texas VA Health Care System in Big Spring, Texas. This procurement is conducted as a new delivery order against Federal Supply Schedule contract 36F79720D0227. The contract covers various strengths of Lenalidomide capsules, ranging from 2.5mg to 25mg, with a period of performance from October 2, 2025, through September 30, 2026. Due to strict FDA-mandated Risk Evaluation and Mitigation Strategy (REMS) requirements designed to prevent embryo-fetal risk, this is a sole-source acquisition under FAR 8.405-6. Exelan Pharmaceuticals Inc. is identified as the sole manufacturer, and Biologics by McKesson is the sole authorized distributor. Compliance with the REMS program, including prescriber and pharmacy certification and patient enrollment, is a mandatory condition for award and performance. Because of these regulatory constraints and the proprietary nature of the distribution network, no small business alternatives are available, and the award is based on the unique capability of the selected large business entities to meet federal safety mandates.
General Info
Contract Value
$899,347.26Place of Performance
Big Spring, TX, 79720, USASet-Aside
Awardee
EXELAN PHARMACEUTICALS INCAward Issued Date
Documents
1AI Contract Breakdown
Uniform Contract FormatSign up to view the full breakdown with detailed analysis of each section.
View Full BreakdownThis one is closed. Find the next one like it.
Open contracts like this one, right now:
- Sodium Chloride 0.9% Injection SupplierOpen now, due in 7 days
- Supply of Surgical Detergent (Chlorhexidine Gluconate)Open now, due in 7 days
Ask CLEATUS
I've read this contract. Ask me anything.
Timeline
Organization & Contact Information
Full Description
Lenalidomide is an oral immunomodulatory medication that treats several types of blood cancers. The purpose of this contract is to establish a reliable and continuous supply of lenalidomide primarily used to treat multiple myeloma, anemia in myelodysplastic syndromes, and certain types of lymphoma.
More opportunities from Department Of Veterans Affairs → 257-NETWORK Contract Office 17 (36C257)
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
